Similar articles

• Metergoline as a lactation inhibitor.

  Caballero A Sr, Palomo A, Molina CE, Albarrán FJ, Caballero A Jr, Mena P. Caballero A Sr, et al. J Reprod Med. 1982 Apr;27(4):202-6. J Reprod Med. 1982. PMID: 7097670
• [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].

  Vecchione A, Baccolo M. Vecchione A, et al. Riv Ital Ginecol. 1980;59(2-3):311-9. Riv Ital Ginecol. 1980. PMID: 7020052 Clinical Trial. Italian. No abstract available.
• [Inhibition of puerperal lactation with bromocriptine and methergoline. Clinical evaluation].

  Albertazzi E, Bartolotti A, Turci M. Albertazzi E, et al. Riv Ital Ginecol. 1980;59(4-5):435-41. Riv Ital Ginecol. 1980. PMID: 7313403 Italian. No abstract available.
• Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.

  Ferrari C, Reschini E, Peracchi M, Crosignani PG. Ferrari C, et al. Gynecol Obstet Invest. 1980;11(1):1-16. doi: 10.1159/000299801. Gynecol Obstet Invest. 1980. PMID: 6248438 Review. No abstract available.
• Proceedings: Neuroendocrinology of lactation.

  Meites J. Meites J. J Invest Dermatol. 1974 Jul;63(1):119-24. doi: 10.1111/1523-1747.ep12678113. J Invest Dermatol. 1974. PMID: 4209750 Review. No abstract available.